Epigenorm Antivir Combined With Acupuncture for the Treatment of Osteoarthritis Patients Who Are Overweight or Obese

NCT03540186 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-07-02

No results posted yet for this study

Summary

The study evaluates analgesic, antiinflammatory and metabolic effects of a supplement Epigenome-Antivir (extracts of glycyrrhiza roots, hippophae rhamnoides leaves, curcumin, green tea, and vitamin C) combined with acupuncture in patients with knee osteoarthritis (OA) and metabolic syndrome.

Conditions

Interventions

DIETARY_SUPPLEMENT

Epigenorm Antivir

1 capsule of Epigenorm Antivir twice daily for 3 months

PROCEDURE

Acupuncture

Acupuncture involves inserting sterile needles into the skin. The needles do not go into the skin very far. Number of acupuncture sessions: no less than 15 sessions, based on the physician discretion

Sponsors & Collaborators

  • Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

    lead OTHER

Principal Investigators

  • Ivan Shirinsky, MD, PhD · Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540186 on ClinicalTrials.gov